title: Pharmacoeconomic impact of a weight-based heparin protocol.
authors.affiliation: Methodist Hospital, Houston, TX 77030, USA. cbowden@tmh.tmc.edu
authors.forename: C
authors.initials: C
authors.lastname: Bowden
authors.forename: K
authors.initials: K
authors.lastname: Carter
authors.forename: K
authors.initials: K
authors.lastname: Birtcher
authors.forename: K
authors.initials: K
authors.lastname: Chellam
authors.forename: T
authors.initials: T
authors.lastname: Schwartz
authors.forename: J
authors.initials: J
authors.lastname: Buban
authors.forename: N
authors.initials: N
authors.lastname: Sarkissian
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000789:Angina, Unstable / Q000150:complications / Q000188:drug therapy* / Q000191:economics; D000925:Anticoagulants / Q000191:economics* / Q000627:therapeutic use; D001835:Body Weight; D005260:Female; D006493:Heparin / Q000008:administration & dosage / Q000191:economics*; D017721:Hospital Costs; D006801:Humans; D007902:Length of Stay; D008297:Male; D008499:Medical Records; D008875:Middle Aged; D010314:Partial Thromboplastin Time; D012189:Retrospective Studies; D012720:Severity of Illness Index; D013781:Texas; D013923:Thromboembolism / Q000150:complications / Q000188:drug therapy* / Q000191:economics
chemical_list: D000925:Anticoagulants; D006493:Heparin